BSc (Hons), MSc
Executive Assistant to Professor Pollard
Louise joined the team in April 2020. She provides executive and administrative support to Professor Pollard in his research and clinical activities, both at the Children’s Hospital and at the Oxford Vaccine Group.
Louise joined us from the Metropolitan Police Service where she served for 5 years as a police officer, and prior to that undertook administrative roles including at the John Radcliffe Hospital, Oxford. She has a Master’s degree in Crime Science, Intelligence and Investigation and a Bachelor’s degree in Criminology with Psychology.
Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.
Ramasamy MN. et al, (2021), Lancet, 396, 1979 - 1993
Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil
Clemens SAC. et al, (2021), Nature Communications, 12
Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002).
Flaxman A. et al, (2021), Lancet, 398, 981 - 990
Author Correction: Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses.
Barrett JR. et al, (2021), Nat Med, 27
Author Correction: T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial.
Ewer KJ. et al, (2021), Nat Med, 27